Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis. Issue 2 (8th December 2016) - Hartery, K.
Abstract : Linked Content This article is linked to Stallmach et al paper. To view this article visit https://doi.org/10.1111/apt.13813 .